000 00995 a2200289 4500
005 20250516204742.0
264 0 _c20140527
008 201405s 0 0 eng d
022 _a1572-0241
024 7 _a10.1038/ajg.2013.482
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPraveen, Sharma
245 0 0 _aResponse to Congly and Leise.
_h[electronic resource]
260 _bThe American journal of gastroenterology
_cApr 2014
300 _a598-9 p.
_bdigital
500 _aPublication Type: Letter; Comment
650 0 4 _aFemale
650 0 4 _aGastrointestinal Agents
_xtherapeutic use
650 0 4 _aHepatic Encephalopathy
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aLactulose
_xtherapeutic use
650 0 4 _aMale
650 0 4 _aRifamycins
_xtherapeutic use
700 1 _aChander, Sharma Barjesh
773 0 _tThe American journal of gastroenterology
_gvol. 109
_gno. 4
_gp. 598-9
856 4 0 _uhttps://doi.org/10.1038/ajg.2013.482
_zAvailable from publisher's website
999 _c23705190
_d23705190